Clinical Trials Directory

Trials / Terminated

TerminatedNCT03212976

Clinical Efficacy of a Non-Invasive Measure of Intracranial Pressure

Assessment of the Clinical Efficacy of a Non-Invasive Measurement of Intracranial Pressure by Magnetic Resonance Phase Contrast Imaging

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
11 (actual)
Sponsor
University of Miami · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Accepted

Summary

This study is designed to evaluate the accuracy of a non-invasive method phase-contrast magnetic resonance imaging (MR-ICP) for assessing intracranial pressure (Phase 1). To perform second phase contrast imaging to evaluate the patency and flow of ventricular catheters after MR-ICP imaging (Phase 2).

Detailed description

The study will be divided into 2 phases. In Phase 1, patients with an intracranial pressure monitor will be recruited to the study, while in Phase 2, patients with shunts or Cerebral Spinal Fluid (CSF) access devices (Ommaya, reservoir, etc.) will be eligible for the study. Two separate groups of patients will be recruited to each phase of the study. Each phase of the study will involve MR-ICPs. The MR-ICP is an extra 5-10 minute sequence at the end of a MRI that assesses the pressure in the head. The MRI will take scans of the brain during different phases of the cardiac cycle and will assess the volume changes while the patient is lying flat. The pressure in the head will be estimated based on these calculations. This estimate will be compared to the pressure in the head as determined by the ICP monitor.

Conditions

Interventions

TypeNameDescription
PROCEDUREPhase contrast magnetic resonance imagingPhase-contrast magnetic resonance imaging will be done to assess intracranial pressure

Timeline

Start date
2017-10-26
Primary completion
2020-10-15
Completion
2020-10-15
First posted
2017-07-11
Last updated
2024-12-05

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03212976. Inclusion in this directory is not an endorsement.